Literature DB >> 25801490

Clonal evolution of acute myeloid leukemia relapsed after 19 years of remission.

Koichi Takahashi1,2, Whijae Roh3,4, Jianhua Zhang5, Alexei Propotopov5, Keyur Patel6, Stephen Strickland7, Annette Kim7, Cindy Vnencak-Jones7, Sarah Pelletier1, Simrit Parmar8, Guillermo Garcia-Manero1, Steven Kornblau1, Lynda Chin3,5, Hagop Kantarjian1, P Andrew Futreal3, Farhad Ravandi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25801490      PMCID： PMC4948743          DOI： 10.1002/ajh.24009

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

1.  The EMT regulator Zeb2/Sip1 is essential for murine embryonic hematopoietic stem/progenitor cell differentiation and mobilization.

Authors:  Steven Goossens; Viktor Janzen; Sonia Bartunkova; Tomomasa Yokomizo; Benjamin Drogat; Mihaela Crisan; Katharina Haigh; Eve Seuntjens; Lieve Umans; Tamara Riedt; Pieter Bogaert; Lieven Haenebalcke; Geert Berx; Elaine Dzierzak; Danny Huylebroeck; Jody J Haigh
Journal:  Blood       Date:  2011-02-25       Impact factor: 22.113

2.  Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm.

Authors:  J Menezes; F Acquadro; M Wiseman; G Gómez-López; R N Salgado; J G Talavera-Casañas; I Buño; J V Cervera; S Montes-Moreno; J M Hernández-Rivas; R Ayala; M J Calasanz; M J Larrayoz; L F Brichs; M Gonzalez-Vicent; D G Pisano; M A Piris; S Álvarez; J C Cigudosa
Journal:  Leukemia       Date:  2013-09-27       Impact factor: 11.528

3.  Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years).

Authors:  Bruno C Medeiros; Mark D Minden; Andre C Schuh; Aaron D Schimmer; Karen Yee; Jeff H Lipton; Hans A Messner; Vikas Gupta; Kathy Chun; Wei Xu; Prabodh Das; Suzanne Kamel-Reid; Joseph M Brandwein
Journal:  Leuk Lymphoma       Date:  2007-01

4.  Late relapses in acute myeloid leukemia: analysis of characteristics and outcome.

Authors:  Dushyant Verma; Hagop Kantarjian; Stefan Faderl; Susan O'Brien; Sherry Pierce; Khanh Vu; Emil Freireich; Michael Keating; Jorge Cortes; Farhad Ravandi
Journal:  Leuk Lymphoma       Date:  2010-05

5.  Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.

Authors:  Li Ding; Timothy J Ley; David E Larson; Christopher A Miller; Daniel C Koboldt; John S Welch; Julie K Ritchey; Margaret A Young; Tamara Lamprecht; Michael D McLellan; Joshua F McMichael; John W Wallis; Charles Lu; Dong Shen; Christopher C Harris; David J Dooling; Robert S Fulton; Lucinda L Fulton; Ken Chen; Heather Schmidt; Joelle Kalicki-Veizer; Vincent J Magrini; Lisa Cook; Sean D McGrath; Tammi L Vickery; Michael C Wendl; Sharon Heath; Mark A Watson; Daniel C Link; Michael H Tomasson; William D Shannon; Jacqueline E Payton; Shashikant Kulkarni; Peter Westervelt; Matthew J Walter; Timothy A Graubert; Elaine R Mardis; Richard K Wilson; John F DiPersio
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962

6.  ASXL1, TP53 and IKZF3 mutations are present in the chronic phase and blast crisis of chronic myeloid leukemia.

Authors:  J Menezes; R N Salgado; F Acquadro; G Gómez-López; M C Carralero; A Barroso; F Mercadillo; L Espinosa-Hevia; J G Talavera-Casañas; D G Pisano; S Alvarez; J C Cigudosa
Journal:  Blood Cancer J       Date:  2013-11-08       Impact factor: 11.037
  6 in total
  1 in total

1.  Late relapse in acute myeloid leukemia (AML): clonal evolution or therapy-related leukemia?

Authors:  Musa Yilmaz; Feng Wang; Sanam Loghavi; Carlos Bueso-Ramos; Curtis Gumbs; Latasha Little; Xingzhi Song; Jianhua Zhang; Tapan Kadia; Gautam Borthakur; Elias Jabbour; Naveen Pemmaraju; Nicholas Short; Guillermo Garcia-Manero; Zeev Estrov; Hagop Kantarjian; Andrew Futreal; Koichi Takahashi; Farhad Ravandi
Journal:  Blood Cancer J       Date:  2019-01-16       Impact factor: 11.037
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.